CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0.0%

Compliant submissions 0

Incompliant submissions 1

Total trials 1

My Organizations' Clinical Trials

Showing 100 of 361 entries

View as:

Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01081873 Org: User:

Start: 06/30/04 End: 12/31/10 Due: 12/31/11

Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT00645814 Org: User:

Start: 03/31/03 End: - Due: -

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00234936 Org: User:

Start: 12/31/03 End: - Due: -

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Phase: N/A Priority: Normal

NCT ID: NCT00234988 Org: User:

Start: 06/30/04 End: - Due: -

A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2

Phase: N/A Priority: Normal

NCT ID: NCT02009410 Org: User:

Start: 11/30/13 End: 08/31/14 Due: 08/31/15

Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)

Phase: N/A Priority: Normal

NCT ID: NCT00307827 Org: User:

Start: 04/30/06 End: 11/30/07 Due: 11/30/08

A Study of Leuprolide to Treat Prostate Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00626431 Org: User:

Start: 02/29/08 End: 09/30/09 Due: 09/30/10

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

Phase: N/A Priority: Normal

NCT ID: NCT00048542 Org: User:

Start: 09/30/02 End: 06/30/10 Due: 06/30/11

Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01401933 Org: User:

Start: 05/31/11 End: 10/31/11 Due: 10/31/12

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT00073125 Org: User:

Start: 05/31/03 End: - Due: -

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Phase: N/A Priority: Normal

NCT ID: NCT00002366 Org: User:

Start: - End: - Due: -

A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency

Phase: N/A Priority: Normal

NCT ID: NCT00401076 Org: User:

Start: 07/31/08 End: 09/30/10 Due: 09/30/11

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

Phase: N/A Priority: Normal

NCT ID: NCT00048516 Org: User:

Start: 02/28/02 End: - Due: -

Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00562887 Org: User:

Start: 11/30/07 End: - Due: -

Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00233558 Org: User:

Start: 06/30/05 End: - Due: -

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal

NCT ID: NCT00408629 Org: User:

Start: 11/30/06 End: 03/31/10 Due: 03/31/11

Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain

Phase: N/A Priority: Normal

NCT ID: NCT00941746 Org: User:

Start: 08/31/09 End: 01/31/11 Due: 01/31/12

Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine

Phase: N/A Priority: Normal

NCT ID: NCT00195806 Org: User:

Start: 02/28/05 End: - Due: -

Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00195689 Org: User:

Start: 08/31/03 End: - Due: -

Special Investigation of Kaletra in Pregnant Women

Phase: N/A Priority: Normal

NCT ID: NCT01076985 Org: User:

Start: 12/31/00 End: 12/31/10 Due: 12/31/11

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

Phase: N/A Priority: Normal

NCT ID: NCT00646711 Org: User:

Start: 02/28/03 End: 12/31/03 Due: 12/31/04

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

Phase: N/A Priority: Normal

NCT ID: NCT00839293 Org: User:

Start: 02/28/09 End: - Due: -

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

Phase: N/A Priority: Normal

NCT ID: NCT00909636 Org: User:

Start: 05/31/09 End: - Due: -

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Phase: N/A Priority: Normal

NCT ID: NCT00743470 Org: User:

Start: 08/31/08 End: - Due: -

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal

NCT ID: NCT00100685 Org: User:

Start: 01/31/05 End: 12/31/07 Due: 12/31/08

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer	NCT01081873	Abbott	user2@example.com	None	2004-06-30	2010-12-31	2011-12-31	-	-	2025-07-14
Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis	NCT00645814	Abbott	user2@example.com	None	2003-03-31	-	-	-	-	2025-07-14
Quality of Life Study With Adalimumab in Rheumatoid Arthritis	NCT00234936	Abbott	user2@example.com	None	2003-12-31	-	-	-	-	2025-07-14
A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.	NCT00234988	Abbott	user2@example.com	None	2004-06-30	-	-	-	-	2025-07-14
A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2	NCT02009410	Abbott	user2@example.com	None	2013-11-30	2014-08-31	2015-08-31	-	-	2025-07-14
Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)	NCT00307827	Abbott	user2@example.com	None	2006-04-30	2007-11-30	2008-11-30	-	-	2025-07-14
A Study of Leuprolide to Treat Prostate Cancer	NCT00626431	Abbott	user2@example.com	None	2008-02-29	2009-09-30	2010-09-30	-	-	2025-07-14
Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)	NCT00048542	Abbott	user2@example.com	None	2002-09-30	2010-06-30	2011-06-30	-	-	2025-07-14
Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors	NCT01401933	Abbott	user2@example.com	None	2011-05-31	2011-10-31	2012-10-31	-	-	2025-07-14
Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma	NCT00073125	Abbott	user2@example.com	None	2003-05-31	-	-	-	-	2025-07-14
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma	NCT00002366	Abbott	user2@example.com	None	-	-	-	-	-	2025-07-14
A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insufficiency	NCT00401076	Abbott	user2@example.com	None	2008-07-31	2010-09-30	2011-09-30	-	-	2025-07-14
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)	NCT00048516	Abbott	user2@example.com	None	2002-02-28	-	-	-	-	2025-07-14
Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease	NCT00562887	Abbott	user2@example.com	None	2007-11-30	-	-	-	-	2025-07-14
Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid Arthritis	NCT00233558	Abbott	user2@example.com	None	2005-06-30	-	-	-	-	2025-07-14
Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis	NCT00408629	Abbott	user2@example.com	None	2006-11-30	2010-03-31	2011-03-31	-	-	2025-07-14
Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain	NCT00941746	Abbott	user2@example.com	None	2009-08-31	2011-01-31	2012-01-31	-	-	2025-07-14
Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine	NCT00195806	Abbott	user2@example.com	None	2005-02-28	-	-	-	-	2025-07-14
Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis	NCT00195689	Abbott	user2@example.com	None	2003-08-31	-	-	-	-	2025-07-14
Special Investigation of Kaletra in Pregnant Women	NCT01076985	Abbott	user2@example.com	None	2000-12-31	2010-12-31	2011-12-31	-	-	2025-07-14
Pediatric Switch Study for Children and Adolescent Patients With Epilepsy	NCT00646711	Abbott	user2@example.com	None	2003-02-28	2003-12-31	2004-12-31	-	-	2025-07-14
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules	NCT00839293	Abbott	user2@example.com	None	2009-02-28	-	-	-	-	2025-07-14
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet	NCT00909636	Abbott	user2@example.com	None	2009-05-31	-	-	-	-	2025-07-14
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects	NCT00743470	Abbott	user2@example.com	None	2008-08-31	-	-	-	-	2025-07-14
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)	NCT00100685	Abbott	user2@example.com	None	2005-01-31	2007-12-31	2008-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance